Article
The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.
BMC cancer - 20 Nov 2009
Castillejo Adela, Mata-Balaguer Trinidad, Guarinos Carla, Castillejo María-Isabel, Martínez-Cantó Ana, Barberá Víctor-Manuel, Montenegro Paola, Ochoa Enrique, Lázaro Rafael, Guillén-Ponce Carmen, Carrato Alfredo, Soto José-Luís
Abstract excerpt
BACKGROUND: The Int7G24A variant of transforming growth factor-beta receptor type I (TGFBR1) has been shown to increase the risk for kidney, ovarian, bladder, lung and breast cancers. Its role in colorectal cancer (CRC) has not been established. The aims of this study were to assess the association of TGFBR1*Int7G24A variant with CRC occurrence, patient age, gender, tumour location and stage. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
